Table 2 Number of Falls during the 4-year follow-up according to the Baseline Characteristics of the Study Population
Variable n (%) | No fall (n = 3670) | One fall (n = 1291) | ≥ 2 falls (n = 1382) | crude p-value |
|---|---|---|---|---|
Women | 1922 (52) | 833 (65) | 987 (71) | <.001 |
Age (years) | ||||
<75 | 2364 (64) | 733 (57) | 707 (51) | <.001 |
75–79 | 886 (24) | 364 (28) | 419 (30) | |
≥80 | 420 (12) | 194 (15) | 256 (19) | |
Living alone | 1107 (30) | 494 (38) | 574 (41) | <.001 |
Years of schooling | ||||
≤5 | 1204 (33) | 420 (33) | 474 (34) | .86 |
6–9 | 1086 (30) | 378 (29) | 400 (29) | |
10–12 | 479 (13) | 183 (14) | 185 (14) | |
≥13 | 901 (24) | 308 (24) | 322 (23) | |
Body Mass Index | ||||
<25 | 1701 (46) | 641 (50) | 648 (48) | .09 |
25–29 | 1489 (41) | 478 (37) | 524 (38) | |
≥30 | 464 (13) | 166 (13) | 196 (14) | |
Depressive symptoms* | 369 (10) | 176 (14) | 201 (15) | <.001 |
MMSE ≥ 28† | 2117 (58) | 748 (58) | 762 (55) | .24 |
Impaired mobility‡ | 1351 (37) | 579 (46) | 724 (53) | <.001 |
Diurnal drowsiness | 554 (16) | 206 (17) | 259 (21) | .001 |
Number of drugs used ≥ 5 § | 1140 (31) | 459 (36) | 573 (41) | <.001 |
At least one inappropriate medication | 1092 (30) | 408 (32) | 504 (36) | <.001 |